scholarly journals Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study

Blood ◽  
2013 ◽  
Vol 122 (17) ◽  
pp. 2965-2973 ◽  
Author(s):  
Conrad Russell Y. Cruz ◽  
Kenneth P. Micklethwaite ◽  
Barbara Savoldo ◽  
Carlos A. Ramos ◽  
Sharon Lam ◽  
...  
Keyword(s):  
T Cells ◽  
Stem Cell ◽  
B Cell ◽  
Stem Cell Transplant ◽  
Phase 1 ◽  
Cell Transplant ◽  
Allogeneic Stem Cell Transplant ◽  
B Cell Malignancies ◽  
Phase 1 Study ◽  
Key Points

Key Points Allogeneic CD19-CAR VSTs are well tolerated by patients with relapsed B-cell malignancies post-HSCT. At periods of CD19-CAR VST persistence, these cells demonstrate antitumor activity.

Long-term survival after allogeneic stem cell transplant for relapsed large B cell lymphomas: a retrospective study

2011 ◽  
Vol 53 (3) ◽  
pp. 503-505
Author(s):  
Vladimir Lazarevic ◽  
Mats Remberger ◽  
Hans Hägglund ◽  
Gunnar Juliusson ◽  
Hamdy Omar ◽  
...  
Keyword(s):  
Stem Cell ◽  
Retrospective Study ◽  
B Cell ◽  
Stem Cell Transplant ◽  
Cell Transplant ◽  
Allogeneic Stem Cell Transplant ◽  
Term Survival ◽  
Long Term Survival ◽  
Large B Cell

scholarly journals Transmission of diffuse large B-cell lymphoma by an allogeneic stem-cell transplant

Haematologica ◽  
2018 ◽  
Vol 104 (4) ◽  
pp. e174-e177 ◽  
Author(s):  
Shamzah Araf ◽  
Jun Wang ◽  
Margaret Ashton-Key ◽  
Koorosh Korfi ◽  
Doriana Di Bella ◽  
...  
Keyword(s):  
Stem Cell ◽  
B Cell ◽  
Stem Cell Transplant ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Cell Transplant ◽  
Allogeneic Stem Cell Transplant ◽  
Large B Cell Lymphoma ◽  
Large B Cell
Sign in / Sign up

Export Citation Format

Share Document